Showing results (691-700 of 1,238) with videos related to
Sort By:
Pageof 124
Cancer Treatment and Research Communications|June 12, 2021
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapyChristina Baik, Sylvia Lee, Kitty Cook, et al.Cancer Treatment and Research Communications|April 14, 2023
A low risk of recurrence after breast-conserving surgery for DCIS: A single-institution experienceSara van Bekkum, Caroline Drukker, Joost van Rosmalen, et al.Cancer Treatment and Research Communications|April 15, 2023
Challenges in the management of colorectal cancer in low- and middle-income countriesShah Zeb Khan, Csongor György LengyelCancer Treatment and Research Communications|May 13, 2023
Assessing knowledge, attitude and practice towards prostate cancer screening among males in Southwest Tanzania: A cross-sectional studyMariam L Makungu, Clement N MweyaCancer Treatment and Research Communications|August 11, 2020
The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapyVinicius Ernani, Adams Kusi Appiah, Michael J Baine, et al.Cancer Treatment and Research Communications|August 1, 2020
Factors influencing lung cancer screening completion following participation in shared decision-making: A retrospective study in a U.S. academic health systemLior Rennert, Lu Zhang, Brandon Lumsden, et al.Cancer Treatment and Research Communications|August 4, 2020
PARP inhibitors in castration-resistant prostate cancerAbhishek Tripathi, Pragathi Balakrishna, Neeraj AgarwalCancer Treatment and Research Communications|August 10, 2020
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family membersMichael J Diaz, Boris I Chobrutskiy, Saif Zaman, et al.Cancer Treatment and Research Communications|April 9, 2023
Compliance to adjuvant endocrine therapy and survival in breast cancer patientsChaido Chamalidou, Salmir Nasic, Barbro LinderholmCancer Treatment and Research Communications|April 12, 2023
Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrestFarnoush Kabiri, Abdallah Medlej, Ali Jason Saleh, et al.Pageof 124